News Focus
News Focus
icon url

ApollyonZ

08/16/19 10:43 AM

#40642 RE: MasterChi #40607

$LAHO Banking-wallstreet pouring investment in Stem Cells. Given the economic uncertainty and or reset, best to investment in the future of medicine.

Goldman Sachs highlighted..$12 billion private biotech startup
..Money is pouring in to a hot new area of science


ttps://www.businessinsider.com/venture-capital-interest-in-regenerative-medicine-2017-4
https://www.goldmansachs.com/insights/pages/from_briefings_10-dec-2018.html

The Stem Cell Group
@StemCellGroupUS

We've brought together eight companies on the cutting edge of #healing into one global network. #stemcell

https://mobile.twitter.com/StemCellGroupUS
http://www.stemcellsgroup.com/our-story/


..Stem Cell Center, Inc. is the world's largest collective support & advisory network of regenerative medicine clinics and and physicians

http://stemcellcenter.net/

stemcelltraining
cellgenic
adimarket
Global Stem Cell Foundation
stemcellcenter
Stem Cell Symposium

http://adimarket.info/story/

We’re positioning Adimarket to become the largest e-commerce marketplace for all things regenerative medicine,” says Benito Novas, founder and CEO of Global Stem Cells Group.

http://www.stemcellsgroup.com/adimarket-launches-website/

..One of the biggest investment opportunities over the next decade will be in companies working to delay human death, a market expected to be worth at least $600 billion by 2025..

https://www.worldstemcellsummit.com/2019/05/09/human-lifespan-could-soon-pass-100-years-thanks-to-medical-tech-says-bank-of-america/

..global stem cell therapy..average growth rate of 46.8%
https://www.marketwatch.com/press-release/stem-cell-therapy-market-2019-global-industry-trends-statistics-competition-strategies-revenue-analysis-key-players-regional-analysis-by-forecast-to-2024-2019-06-27


3D Bioprinting Market To Reach USD 4.40 Billion

https://www.globenewswire.com/news-release/2019/05/02/1815536/0/en/3D-Bioprinting-Market-To-Reach-USD-4-40-Billion-By-2026-Reports-And-Data.html

..$20 billion in mergers and acquisitions


https://www.spglobal.com/marketintelligence/en/news-insights/trending/nATYU0f9Kb7ki7MR_mlO-A2

..upsurge in venture capital investment represents growth of 7,300%

https://www.prnewswire.com/news-releases/global-regenerative-medicine-rm-market-report-2019-big-pharma-is-demonstrating-an-interest-in-regenerative-medicine-300872108.html

..Stem Cell Banking Market to Witness Astonishing Growth

https://www.aglobalmarketresearch.com/stem-cell-banking-market-to-witness-astonishing-growth-of-10-cagr-by-2026-with-key-players-cord-blood-registry-cbr-systems-cordlife-group-limited-cryo-cell-international-viacord-cryo-save/



Beike is the world’s largest stem cell provider focusing on the research, development, and clinical translation of adult stem cells.

https://beikebiotech.com


Each sector of GSCG has enormous investments pouring in.

$600 Billion Market, a fraction of that market is sealed signed with GSCG$$$. Consider 2 clinical trails, Medical Devices, Stem Bank, Provider training-marketing-certification, regenerative care...Goldman and BOFA know and so does Big Pharma.

GSCG is worth far north more than a penny, it's closest competition is trading one dollar fifty two, the other is one of the largest in China.